首页> 外文OA文献 >Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes
【2h】

Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes

机译:通过有针对性的序列变化,提高可溶性和重组的天然类似HIV-1包膜糖蛋白三聚体的表达和纯化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Soluble, recombinant native-like envelope glycoprotein (Env) trimers of various human immunodeficiency virus type 1 (HIV-1) genotypes are being developed for structural studies and as vaccine candidates aimed at the induction of broadly neutralizing antibodies (bNAbs). The prototypic design is designated SOSIP.664, but many HIV-1 env genes do not yield fully native-like trimers efficiently. One such env gene is CZA97.012 from a neutralization-resistant (tier 2) clade C virus. As appropriately purified, native-like CZA97.012 SOSIP.664 trimers induce autologous neutralizing antibodies (NAbs) efficiently in immunized rabbits, we sought to improve the efficiency with which they can be produced and to better understand the limitations to the original design. By using structure- and antigenicity-guided mutagenesis strategies focused on the V2 and V3 regions and the gp120-gp41 interface, we developed the CZA97 SOSIP.v4.2-M6.IT construct. Fully native-like, stable trimers that display multiple bNAb epitopes could be expressed from this construct in a stable CHO cell line and purified at an acceptable yield using either a PGT145 or a 2G12 bNAb affinity column. We also show that similar mutagenesis strategies can be used to improve the yields and properties of SOSIP.664 trimers of the DU422, 426c, and 92UG037 genotypes.IMPORTANCE Recombinant trimeric proteins based on HIV-1 env genes are being developed for future vaccine trials in humans. A feature of these proteins is their mimicry of the envelope glycoprotein (Env) structure on virus particles that is targeted by neutralizing antibodies, i.e., antibodies that prevent cells from becoming infected. The vaccine concept under exploration is that recombinant trimers may be able to elicit virus-neutralizing antibodies when delivered as immunogens. Because HIV-1 is extremely variable, a practical vaccine may need to incorporate Env trimers derived from multiple different virus sequences. Accordingly, we need to understand how to make recombinant trimers from many different env genes. Here, we show how to produce trimers from a clade C virus, CZA97.012, by using an array of protein engineering techniques to improve a prototypic construct. We also show that the methods may have wider utility for other env genes, thereby further guiding immunogen design
机译:正在开发各种人类免疫缺陷病毒1型(HIV-1)基因型的可溶性重组天然样包膜糖蛋白(Env)三聚体,用于结构研究,并作为候选疫苗,旨在诱导广泛中和的抗体(bNAb)。原型设计命名为SOSIP.664,但是许多HIV-1 env基因不能有效产生完全像天然的三聚体。一种这样的env基因是来自抗中和性(2级)进化枝C病毒的CZA97.012。作为适当纯化的,类似天然的CZA97.012 SOSIP.664三聚体,可以在免疫兔中有效诱导自体中和抗体(NAbs),我们试图提高其产生效率,并更好地理解原始设计的局限性。通过使用针对V2和V3区域以及gp120-gp41接口的结构和抗原性指导的诱变策略,我们开发了CZA97 SOSIP.v4.2-M6.IT构建体。可以在稳定的CHO细胞系中从该构建体表达完全天然的,稳定的,显示多个bNAb表位的三聚体,并使用PGT145或2G12 bNAb亲和柱以可接受的产率纯化。我们还显示出相似的诱变策略可用于提高SOSIP.664 DU422、426c和92UG037基因型三聚体的产量和特性重要提示正在开发基于HIV-1 env基因的重组三聚体蛋白,用于未来的疫苗试验人类。这些蛋白质的一个特征是它们模仿病毒颗粒上的包膜糖蛋白(Env)结构,并被中和抗体(即阻止细胞被感染的抗体)靶向。正在探索的疫苗概念是,重组三聚体作为免疫原递送时可能能够引起病毒中和抗体。由于HIV-1的变异性很大,实际的疫苗可能需要掺入衍生自多种不同病毒序列的Env三聚体。因此,我们需要了解如何从许多不同的env基因制备重组三聚体。在这里,我们展示了如何通过使用一系列蛋白质工程技术来改善C型进化枝C病毒CZA97.012的三聚体,从而改善原型构建。我们还显示该方法可能对其他env基因具有更广泛的用途,从而进一步指导免疫原设计

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号